Zobrazeno 1 - 10
of 505
pro vyhledávání: '"Yi Hsuan Lee"'
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/2fda5d9a963344ceb2f1e1611c70be91
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Although considerable attention has been paid to the application of leadership in virtual communities, the field of live streaming has not been involved. This exploratory study aimed to explore how different broadcaster leadership traits (charismatic
Externí odkaz:
https://doaj.org/article/5a7d29f56c724010a8ce4f4540ac1218
Autor:
Yu-Hung Lin, Der-Sheng Han, Yi-Hsuan Lee, Ding-Cheng Chan, Chia-Hsiu Chang, Kuen-Cheh Yang, Fong-Ching Chang
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 5, Pp 620-625 (2024)
Background: Social isolation is increasing in aging societies; however, its relationship with depressed mood and sarcopenia is not well studied. This study aims to examine the influence of social network on depressed mood and sarcopenia among communi
Externí odkaz:
https://doaj.org/article/9ca0dcf5cb334db6b037cf72d115af29
Publikováno v:
Translational Oncology, Vol 49, Iss , Pp 102092- (2024)
CDK4/6 inhibitors combined with endocrine therapy prolonged survival in hormone receptor (HR)-positive and HER2-negative advanced breast cancer. We investigated whether CDK4/6 inhibitors enhance radiosensitivity and their underlying mechanisms of thi
Externí odkaz:
https://doaj.org/article/1de44e4112724428b5c89026680f9140
Autor:
Yu-Yun Shao, Min-Shu Hsieh, Yi-Hsuan Lee, Hung-Wei Hsu, Rita Robin Wo, Han-Yu Wang, Ann-Lii Cheng, Chih-Hung Hsu
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34289- (2024)
The anti-programmed death-ligand 1 (PD-L1) antibody is a standard therapy for advanced hepatocellular carcinoma (HCC). Tumor expression of PD-L1 can be induced upon stimulus. Because cyclin-dependent kinase 9 (CDK9) inhibition reduces the expression
Externí odkaz:
https://doaj.org/article/17d5b1d346e04280aa47dacdb32645f5
Autor:
Yu-Hung Lin, Der-Sheng Han, Yi-Hsuan Lee, Ding-Cheng Chan, Chia-Hsiu Chang, Kuen-Cheh Yang, Fong-Ching Chang
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 5, Pp 628- (2024)
Externí odkaz:
https://doaj.org/article/f1d47070e9fe401d9a03e59aecc4259c
Autor:
Yi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, Chia-Hung Yang, Yu-Ling Hung, Yung-An Chen, Yu-Chieh Lin, Ching-Hung Lin, Jih-Hsiang Lee, Ming-Yang Wang, Wen-Hung Kuo, Yen-Yin Lin, Yen-Shen Lu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are the two most common immune checkpoints targeted in triple-negative breast cancer (BC). Refining patient selection for immunotherapy is non-trivial and finding an
Externí odkaz:
https://doaj.org/article/f6690e509a6a4a4baf5dbc669f38d80f
Autor:
Man-San Zhang, Yi-Chen Yeh, Hsien-Neng Huang, Long-Wei Lin, Yen-Lin Huang, Lei-Chi Wang, Lai-Jin Yao, Tze-Chun Hung, Yu-Fen Tseng, Yi-Hsuan Lee, Wei-Yu Liao, Jin-Yuan Shih, Min-Shu Hsieh
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0301120 (2024)
Determining the exact type of epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutation in lung cancer has become important. We found that not all ex20ins mutations reported by cobas EGFR test v2 could be validated by Sanger sequen
Externí odkaz:
https://doaj.org/article/17f718bdd88b4b328a4f85673a79643c
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 5-6 (2024)
Externí odkaz:
https://doaj.org/article/1a104fe4f7494e8180003add272a5f7d